Posted by

Clinical Trial NCT02043678

Clinical Trial Description A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve subjects with bone predominant metastatic castration-resistant prostate cancer (CRPC) Summary This study is a phase III double blind, placebo controlled, study with a randomization allocation ratio […]